MISSISSAUGA, ON, Nov. 25, 2015 /PRNewswire/ - Cipher
Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the
Company") today announced that Shawn
Patrick O'Brien, President and Chief Executive Officer, and
Norman Evans, Chief Financial
Officer, will present at the 27th Annual Piper Jaffray Healthcare
Conference in New York City on
Wednesday, December 2, 2015 at
3:30 PM ET. A live audio webcast will
be available in the Investor Relations section of the Company's
website at www.cipherpharma.com.
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (NASDAQ:CPHR; TSX:CPH) is a rapidly
growing specialty pharmaceutical dermatology company with a
diversified portfolio of commercial-stage products with the goal of
becoming the most customer-centric dermatology company in
North America.
Cipher has completed seven transactions in 2015, including the
acquisition of Innocutis and its nine branded dermatology products,
to build its U.S. commercial presence, expand its Canadian
dermatology franchise and broaden its pipeline. Cipher is
well-capitalized to drive long-term, sustained earnings growth by
leveraging its proven clinical development capabilities and
efficient commercial execution. For more information, visit
www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.